Postnatal haloperidol eliminates the deficit in circling behavior produced by prenatal exposure to the same drug

Neurotoxicology and Teratology

Volumn 26, Issue 4, 2004, Pages 561-569

  Wolansky, Marcelo Javier ^a,c   Soiza Reilly, Mariano ^a   Fossati, Mariana ^a   Azcurra, Julio Marcos ^a,b  

^a UNIVERSIDAD DE BUENOS AIRES   (Argentina)

^b US EPA ^*  (Argentina)

^c U S ENVIRONMENTAL PROTECTION AGENCY   (United States)

Author keywords

Behavioral teratogen; Haloperidol; Therapeutic agent

Indexed keywords

HALOPERIDOL;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BEHAVIOR DISORDER; BEHAVIOR TERATOLOGY; CIRCLING BEHAVIOR; CONTROLLED STUDY; FEMALE; LACTATION; NONHUMAN; PERINATAL DRUG EXPOSURE; PRENATAL DRUG EXPOSURE; PRIORITY JOURNAL; PROGENY;

ANALYSIS OF VARIANCE; ANIMALS; ANIMALS, NEWBORN; BEHAVIOR, ANIMAL; BRAIN; DOPAMINE ANTAGONISTS; FEMALE; HALOPERIDOL; MALE; PREGNANCY; PRENATAL EXPOSURE DELAYED EFFECTS; RADIOLIGAND ASSAY; RANDOM ALLOCATION; RATS; RATS, SPRAGUE-DAWLEY; SPIPERONE; STEREOTYPED BEHAVIOR; STEREOTYPIC MOVEMENT DISORDER; TRITIUM;

ANIMALIA;

EID: 2942625682     PISSN: 08920362     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ntt.2004.04.006     Document Type: Article

References (67)

1. Andersen S.L., Gazzara R.A. Effects of (-)-sulpiride on dopamine release in striatum of developing rats: degree of depolarization influences responsiveness. J. Neurochem. 67(5):1996;1931-1937
2. Austin M.-P.V., Mitchell P.B. Psychotropic medications in pregnant women: treatment dilemmas. Med. J. Aust. (Australia). 169:1998;428-431
3. Baldessarini R.J., Tarazi F.I. Drugs and the treatment of psychiatric disorders: psychosis and mania. Hardman J.G., Limbird L.E., Goodman Gilman A. The Pharmacological Basis of Therapeutics. tenth edition:2001;485-519 MacGraw-Hill, New York. Chapter 20
4. Barik S., Beaurepaire R. Evidence for a functional role of the dopamine D3 receptors in the cerebellum. Brain Res. 737(1-2):1996;347-350
5. Brusés J.L., Azcurra J.M. The circling training: a behavioral paradigm for functional teratology testing. Conn P.M. Paradigms for the Study of Behavior. Methods Neurosci. vol. 14:1993;166-179 Academic Press, New York
6. Brusés J.L., Berninsone P.M., Ojea S., Azcurra J.M. The circling training rat model as a behavioral teratology test. Pharmacol. Biochem. Behav. 38:1991;739-745
7. Burger J., Gochfield M. Lead and neurobehavioral development in gulls: a model for understanding effects in the laboratory and the field. Neurotoxicology. 18(2):1997;495-506
8. Burke R.E. Postnatal developmental programmed cell death in dopamine neurons. Ann. N.Y. Acad. Sci. 991:2003;69-79
9. Cagiano R., Barfield R.J., White N.R., Pleim E.T., Weinstein M., Cuomo V. Subtle behavioral changes produced in rat pups by in utero exposure to haloperidol. Eur. J. Pharmacol. 157(1):1988;45-50
10. Calabresi P., De Murtas M., Mercuri N.B., Bernardi G. Chronic neuroleptic treatment: D2 dopamine receptor supersensitivity and striatal glutamatergic transmission. Ann. Neurol. 31(4):1992;366-373
11. Castro R., Brito B., Segovia J., Martin-Trujillo J.M., Notario V. Prenatal haloperidol induces a selective reduction in the expression of plasticity-related genes in neonate rat forebrain. Mol. Brain Res. 26(1-2):1994;74-80
12. Chakos M.H., Shirakawa O., Lieberman J., Lee H., Bilder R., Tamminga C. Striatal enlargement in rats chronically treated with neuroleptics. Biol. Psychiatry. 44(8):1998;675-684
13. Coyle J.T., Campochiaro P. Ontogenesis of cholinergic-dopaminergic interactions in the rat striatum: a neurochemical study. J. Neurochem. 27:1976;673-678
14. Creese I., Burt D., Snyder S.H. Dopamine receptor binding predicts clinical and pharmacological potencies of anti-schizophrenic drugs. Science. 192:1976;481-483
15. Cuomo V. Perinatal neurotoxicology of psychotropic drugs. Trends Pharmacol. Sci. 8:1987;346-350
16. Cuomo V., Cagiano R., Renna G., Serinelli A., Brunello N., Racagni G. Comparative evaluation of the behavioral consequences of prenatal and early postnatal exposure to haloperidol in rats. Neurobehav. Toxicol. Teratol. 7(5):1985;489-492
17. Dean J.C., Hailey H., Moore S.J., Lloyd D.J., Turnpenny P.D., Little J. Long term health and neurodevelopment in children exposed to antiepileptic drugs before birth. J. Med. Genet. 39(4):2002;251-259
18. Dewey S.L., Smith G.S., Logan J., Brodie J.D. Effects of central cholinergic blockade on striatal dopamine release measured with positron emission tomography in normal human subjects. Proc. Natl. Acad. Sci. U. S. A. 90:1993;11816-11820
19. Eastwood S.L., Hefferman J., Harrison P.J. Chronic haloperidol treatment differentially affects the expression of synaptic and neuronal plasticity-associated genes. Mol. Psychiatry. 2(4):1997;322-329
20. Faustman E.M., Oinenn G.S. Risk assessment. Klassen C.D. Casarett and Doull's Toxicology, The Basic Science of Poisons. sixth edition:2001;93-94 McGraw-Hill, New York
21. Fox C.A., Mansour A., Watson S.J. Jr. The effects of haloperidol on dopamine receptor gene expression. Exp. Neurol. 130(2):1994;288-303
22. Freed C.R., Yamamoto B.K. Regional brain dopamine metabolism: a marker for speed, direction, and posture of moving animals. Science. 229:1985;62-65
23. Galili R., Mosberg, Gil-Ad I., Weizman A., Melamed E., Offen D. Haloperidol-induced neurotoxicity. Possible implications for tardive dyskinesia. J. Neural Transm. 107(4):2000;479-490
24. Gjere N.A. Psychopharmacology in pregnancy. J. Perinat. Neonatal Nurs. 14(4):2001;12-35
25. Heyman G.M., Beer B. A new approach for evaluating the behavioral effects of antipsychotic drugs. TIPS. 8:1987;388-393
26. Hill H.F., Engblom J. Effects of pre- and postnatal haloperidol administration to pregnant and nursing rats on brain catecholamine levels in their offspring. Dev. Pharmacol. Ther. 7:1984;188-197
27. Ibarra G.R., Paratcha G.C., Wolansky M.J., Azcurra J.M. Co-alteration of dopamine D2 receptor and muscarinic acetylcholine receptor binding in rat striatum after circling training. NeuroReport. 7(15-17):1996;2491-2494
28. Imperato A., Obiunu M.C., Gessa G.L. Is in vivo acetylcholine output under a tonic inhibitory control by dopamine? J. Neural Transm., Suppl. 45:1995;91-102
29. Iñiguez C., Calle F., Marshall E., Carreres J. Morphological effects of chronic haloperidol administration on the postnatal development of the rat striatum. Brain Res. 432(1):1987;27-34
30. Lee M.H., Rabe A. Neocortical transplant in the micrencephalic rat brain: morphology and behavior. Brain Res. Bull. 21(5):1988;813-824
31. Lescaudron L., Stein D.G. Functional recovery following transplants of embryonic brain tissue in rats with lesions of visual, frontal and motor cortex: problems and prospects for future research. Neuropsychologia. 28(6):1990;585-599
32. Levant B., Grigoriadis D.E., De Souza E.B. Relative affinities of dopaminergic drugs at dopamine D2 and D3 receptors. Eur. J. Pharmacol. 278(3):1995;243-247
33. Lowry O.H., Rosebrough N.J., Lewis Farr A., Randall R.J. Protein measurement with Folin phenol reagent. J. Biol. Chem. 158:1951;265-275
34. Marchand R., Lajoie L. Histogenesis of the striatopallidal system in the rat: neurogenesis on its neurons. Neuroscience. 17(3):1986;573-590
35. Middaugh L.D., Zemp J.W. Dopaminergic mediation of long-term behavioral effects of in utero drug exposure. Neurobehav. Toxicol. Teratol. 7:1985;685-689
36. Mihaly G.W., Morgan D.J. Placental drug transfer: effects of gestational age and species. Pharmacol. Ther. 23(2):1983;253-266
37. Miller J.C., Friedhoff A.J. Prenatal neurotransmitter programming of postnatal receptor function. Prog. Brain Res. 73:1988;491-508
38. Mitchell I.J., Cooper A.C., Griffiths M.R., Cooper A.J. Acute administration of haloperidol induces apoptosis of neurons in the striatum and substantia nigra in the rat. Neuroscience. 109(1):2002;89-99
39. Nelson B.K. Evidence for behavioral teratogens in humans. J. Appl. Toxicol. 11(1):1991;33-37
40. Rodier P. Chronology of neuron development: animal studies and their clinical implications. Dev. Med. Child Neurol. 22(4):1980;525-545
41. Rogue P., Hanauer A., Zwiller J., Malaviya A.N., Vincendon G. Up-regulation of dopamine D2 receptor mRNA in rat striatum by chronic neuroleptic treatment. Eur. J. Pharmacol. 207(2):1991;165-168
42. Rosengarten H., Friedhoff A.J. Enduring changes in dopamine receptor cells of pups from drug administration to pregnant and nursing rats. Science. 203:1979;1133-1135
43. Russi G., Girotti P., Cadoni P., Di Chiara G., Consolo S. Neuroleptics increase striatal acetylcholine release by a sequential D1 and D2 receptor mechanism. NeuroReport. 4:1993;1335-1338
44. Saleh M.I., Kostrzewa R.M. MIF-1 attenuates spiroperidol alteration of striatal dopamine D2 receptor ontogeny. Peptides. 10(1):1989;35-39
45. Shimohira M., Iwakawa Y., Kohyama J. Rapid-eye-movement sleep in jittery infants. Early Hum. Dev. 66(1):2002;25-31
46. Singh K.P., Singh M. Effect of prenatal haloperidol exposure on behavioral alteration in rats. Neurotoxicol. Teratol. 24(4):2002;497-502
47. Soiza-Reilly M., Fossati M., Ibarra G.R., Azcurra J.M. Different dopamine D1 and D2 receptors expression after motor activity in the striatal critical period. Brain Res. 1004(1-2):2004;217-221
48. Spear L.P. The adolescent brain and age-related behavioral manifestations. Neurosci. Biobehav. Rev. 24:2000;417-463
49. Spear L.P., File S.E. Methodological considerations in neurobehavioral teratology. Pharmacol. Biochem. Behav. 55(4):1996;455-477
50. Spear L.P., Scalzo F.M. Behavioral, psychopharmacological and neurochemical effects of chronic neuroleptic treatment during development. Riley E.P., Vorhees C.V. Handbook of Behavioral Teratology. 1986;173-184 Plenum, New York. Chapter 8
51. Spigset O., Haag S. Excretion of psychotropic drugs into breast milk: pharmacokinetic overview and therapeutic implications. CNS Drugs. 9:1998;111-134
52. Srivastava L.K., Morency M.A., Mishra R.K. Ontogeny of dopamine D2 receptor mRNA in rat brain. Eur. J. Pharmacol. 225(2):1992;143-150
53. Streissguth A.P., Treder R.P., Barr H.M., Shepard T.H., Bleyer W.A. Aspirin and acetaminophen use by pregnant women and subsequent child IQ and attention decrements. Teratology. 35(2):1987;211-219
54. Swaab D.F., Mirmiran M. The influence of chemicals and environment on brain development: "Behavioral teratology" Prog. Clin. Biol. Res. 163B:1985;447-451
55. Tang K.-C., Low M.J., Grandy D.K., Lovinger D.M. Dopamine-dependent synaptic plasticity in striatum during in vivo development. Proc. Natl. Acad. Sci. U. S. A. 98(3):2001;1255-1260
56. Teischer M.H., Andersen S.L., Hostetter J.C. Jr. Evidence for dopamine receptor pruning between adolescence and adulthood in striatum but not nucleus accumbens. Dev. Brain Res. 89(2):1995;167-172
57. Thomas J.D., Fleming S.L., Riley E.P. Administration of low doses of MK-801 during ethanol withdrawal in the developing rat pup attenuates alcohol's teratogenic effects. Alcohol., Clin. Exp. Res. 26(8):2002;1307-1313
58. Tilson H.A. The concern for developmental neurotoxicology: is it justified and what is being done about it? Environ. Health Perspect. 103(Suppl. 6):1995;147-151
59. Van Vulpen E.H., Van der Kooy D. Striatal cholinergic interneurons: birthdates predict compartmental localization. Dev. Brain Res. 109(1):1998;51-58
60. Vorhees C.V. Developmental neurotoxicity induced by therapeutic and illicit drugs. Environ. Health Perspect. 102(Suppl. 2):1994;145-153
61. Vorhees C.V., Molinow E. Behavioral teratogenesis: long-term influences on behavior from early exposure to environmental agents. Osofsky J.D. Handbook of Infants Development. second edition:1987;913-971 Wiley, New York
62. Watanabe T., Matsuhashi K., Takayama S. Placental and blood-brain barrier transfer following prenatal and postnatal exposures to neuroactive drugs: relationship with partition coefficient and behavioral teratogenesis. Toxicol. Appl. Pharmacol. 105(1):1990;66-77
63. Williams R., Ali S.F., Scalzo F.M., Soliman K., Holson R.R. Prenatal haloperidol exposure: effects on brain weights and caudate neurotransmitter levels in rats. Brain Res. Bull. 29(3-4):1992;449-458
64. Wolansky M.J., Mongiat L., Ibarra G.R., Paratcha G.C., Cabrera R.J., Azcurra J.M. Reduction of sample size per experimental group and time per agent examined in a sensitive rat model for behavioral teratology screening routines. Third World Congress on Alternatives and Animal Use in the Life Sciences, Bologna, Italy, 29th August-2nd September, 1999. Alternatives to Laboratory Animals (ATLA) (Suppl.). 1999;165A
65. Xu S.X., Monsma F.J., Sibley D.R., Creese I. Regulation of D1A and D2 dopamine receptor mRNA during ontogenesis, lesion and chronic antagonist treatment. Life Sci. 50(5):1992;383-396
66. Yanai J., Abu-Roumi M., Silverman W.F., Steingart R.A. Neural grafting as a tool for the study and reversal of neurobehavioral birth defects. Pharmacol. Biochem. Behav. 55(4):1996;673-681
67. Yoshida K., Smith B., Craggs M., Kumar R. Neuroleptic drugs in breast-milk: a study of pharmacokinetics and of possible adverse effects in breast-fed infants. Psychol. Med. 28(1):1998;81-91